impact factor, citescore
logo
 

2013 Vol.31, N°4 - Suppl.78 - Table of contents

Possible Discontinuation of Therapies in Inflammatory Rheumatic Diseases

Possible Discontinuation of Therapies in Inflammatory Rheumatic Diseases

Guest Editors: T. Pincus, J. Braun, A. Kavanaugh, J.S. Smolen

purchase complete issue

Continuing Medical Education Activity

CER6998
2013,31,4,Suppl.78
Pg. 0000

Free to view

Possible discontinuation of therapies in inflammatory rheumatic diseases
T. Pincus, J. Braun, A. Kavanaugh, J.S. Smolen

Rheumatology Abstract

Rheumatology Article

Introduction

CER6956
2013,31,4,Suppl.78
Pg. 0001-0003

Free to view

Possible discontinuation of therapies in inflammatory rheumatic diseases – as with initiation of therapies, a shared decision between patient and rheumatologist
T. Pincus, J. Braun, A. Kavanaugh, J.S. Smolen

Rheumatology Abstract

Rheumatology Article

 

CER6886
2013,31,4,Suppl.78
Pg. 0004-0008

Free to view

Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?
I.C. Scott, G.H. Kingsley, D.L. Scott

Rheumatology Abstract

Rheumatology Article

 

CER6938
2013,31,4,Suppl.78
Pg. 0009-0013

Free to view

The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era
R. Caporali, C.A. Scirè, M. Todoerti, C. Montecucco

Rheumatology Abstract

Rheumatology Article

Rheumatoid arthritis

CER6887
2013,31,4,Suppl.78
Pg. 0014-0018

Free to view

The BeSt way of withdrawing biologic agents
C. Allaart, W. Lems, T. Huizinga

Rheumatology Abstract

Rheumatology Article

 

CER6888
2013,31,4,Suppl.78
Pg. 0019-0021

Free to view

The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials
A. Kavanaugh, J.S. Smolen

Rheumatology Abstract

Rheumatology Article

 

CER6798
2013,31,4,Suppl.78
Pg. 0022-0027

Free to view

Discontinuation of biologics in patients with rheumatoid arthritis
Y. Tanaka, S. Hirata, B. Saleem, P. Emery

Rheumatology Abstract

Rheumatology Article

 

CER6890
2013,31,4,Suppl.78
Pg. 0028-0032

Free to view

Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities
K. Yoshida, H. Radner, A. Kavanaugh, Y.-K. Sung, S.-C. Bae, M. Kishimoto, K. Matsui, M. Okada, S. Tohma, M.E. Weinblatt, D.H. Solomon

Rheumatology Abstract

Rheumatology Article

Spondyloarthropathies (SpA)

CER6891
2013,31,4,Suppl.78
Pg. 0033-0036

Free to view

Remission and possible discontinuation of biological therapy in axial spondyloarthritis
J. Braun, J. Sieper

Rheumatology Abstract

Rheumatology Article

 

CER6893
2013,31,4,Suppl.78
Pg. 0037-0042

Free to view

Withdrawal of biologic therapy in axial spondyloarthritis: the experience in early disease
I.-H. Song, H. Haibel, D. Poddubnyy, J. Braun, J. Sieper

Rheumatology Abstract

Rheumatology Article

 

CER6901
2013,31,4,Suppl.78
Pg. 0043-0046

Free to view

Withdrawal of biologic therapy in axial spondyloarthritis: the experience in established disease
X. Baraliakos, U. Kiltz, F. Heldmann, J. Sieper, J. Braun

Rheumatology Abstract

Rheumatology Article

 

CER6902
2013,31,4,Suppl.78
Pg. 0047-0050

Free to view

Withdrawal of medical therapies in axial spondyloarthritis: what would be the optimal trial design?
U. Kiltz, X. Baraliakos, J. Braun, D. Van Der Heijde

Rheumatology Abstract

Rheumatology Article

Psoriatic arthritis (PsA)

CER6903
2013,31,4,Suppl.78
Pg. 0051-0053

Free to view

Can biologic therapies be withdrawn or tapered in psoriatic arthritis?
A.R. Moverley, L.C. Coates, P.S. Helliwell

Rheumatology Abstract

Rheumatology Article

 

CER6904
2013,31,4,Suppl.78
Pg. 0054-0058

Free to view

Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?
E. Lubrano, E. Soriano, O. Fitzgerald

Rheumatology Abstract

Rheumatology Article

 

CER6916
2013,31,4,Suppl.78
Pg. 0059-0062

Free to view

Is reduction or discontinuation of therapy an acceptable possibility in psoriatic arthritis?
P. Mease

Rheumatology Abstract

Rheumatology Article

 

CER6937
2013,31,4,Suppl.78
Pg. 0063-0070

Free to view

Continuous versus intermittent therapy for moderate-to-severe psoriasis
M.K. Ramirez-Fort, A.A. Levin, S.-C. Au, A.B. Gottlieb

Rheumatology Abstract

Rheumatology Article

Systemic lupus erythematosus

CER6954
2013,31,4,Suppl.78
Pg. 0071-0074

Free to view

Withdrawal of therapy in non-renal systemic lupus erythematosus: is this an achievable goal?
M. Mosca, C. Tani, M. Aringer

Rheumatology Abstract

Rheumatology Article

 

CER6818
2013,31,4,Suppl.78
Pg. 0075-0081

Free to view

What happens after complete withdrawal of therapy in patients with lupus nephritis
G. Moroni, S. Longhi, E. Giglio, P. Messa, C. Ponticelli

Rheumatology Abstract

Rheumatology Article

 

CER6955
2013,31,4,Suppl.78
Pg. 0082-0085

Free to view

New drugs in systemic lupus erythematosus: when to start and when to stop
M. Mosca, R. Van Vollenhoven

Rheumatology Abstract

Rheumatology Article

Vasculitis

CER6930
2013,31,4,Suppl.78
Pg. 0086-0092

Free to view

Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis
F. Muratore, N. Pipitone, G.G. Hunder, C. Salvarani

Rheumatology Abstract

Rheumatology Article

 

CER6917
2013,31,4,Suppl.78
Pg. 0093-0097

Free to view

Discontinuation of therapies in vasculitis
R.A. Luqmani

Rheumatology Abstract

Rheumatology Article

Juvenile arthritis

CER6905
2013,31,4,Suppl.78
Pg. 0098-0101

Free to view

Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis
S. Verazza, G. Negro, D. Marafon, A. Consolaro, A. Martini, A. Ravelli

Rheumatology Abstract

Rheumatology Article

Continuing Medical Education Activity

CER7017
2013,31,4,Suppl.78
Pg. 0102-0107

Free to view

Possible Discontinuation of Therapies in Inflammatory Rheumatic Diseases: CME activity
No Author

Rheumatology Abstract

Rheumatology Article